Split Biosciences, Inc. — Form D
Split Biosciences, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2019-09-10. The offering totals $1.0M, of which $560K was reported sold. Industry: Other.
Offering
- Filed: 2019-09-10
- Form: D
- Accession: 0001755695-19-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $560K
- Remaining: $440K
- Investors: 9
- Date of first sale: 2019-08-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-348355
Issuer
- Name: Split Biosciences, Inc.
- CIK: 0001755695
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: FLUKE HALL, SUITE 304, SEATTLE, WA, 98195
- Phone: 703-401-6022
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Charles Michael Roco | Director | Seattle, WA |
| Alexander Bengt Rosenburg | Director | Seattle, WA |
| Georg Friedrich David Seelig | Director | Seattle, WA |
| Charles Michael Roco | Executive Officer | Seattle, WA |
| Alexander Bengt Rosenburg | Executive Officer | Seattle, WA |
| Charles Michael Roco | Promoter | Seattle, WA |
| Alexander Bengt Rosenburg | Promoter | Seattle, WA |
| Georg Friedrich David Seelig | Director | Seattle, WA |
| Georg Friedrich David Seelig | Executive Officer | Seattle, WA |
| Georg Friedrich David Seelig | Promoter | Seattle, WA |
| Alexander Bengt Rosenberg | Director | Seattle, WA |
| Alexander Bengt Rosenberg | Executive Officer | Seattle, WA |
| Alexander Bengt Rosenberg | Promoter | Seattle, WA |
Other filings by this issuer (1)
More